[Research Report] The prenatal and newborn genetic testing market was valued at US$ 4,034.4 million in 2018 and it is projected to reach US$ 11,204.7 million in 2027; it is expected to grow at a CAGR of 12.2% from 2019 to 2027.
Prenatal genetic testing is performed during the pregnancy for the diagnosis of the diseases or detection of specific genetic abnormalities before 8 to 10 weeks of gestation and also helps to determine the sex of the fetus. Most of the prenatal genetic tests use a blood sample from the mother for conduction of various screens. Diagnostic methods are more effective, accurate, and a preferred option for the detection of chromosome abnormalities as compared to the screening methods. The growth of the global prenatal and newborn genetic testing market is attributed to the increase in the prevalence of genetic diseases among infants, supportive government for promoting the use of prenatal and newborn testing and increasing birth rate. However, risk associated with prenatal genetic tests is the major factor hindering the market growth.
The global prenatal and newborn genetic testing market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Lucrative Regions for Global Prenatal and Newborn Genetic Testing Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
High Prevalence of Genetic Diseases in Infants to Drive Global Prenatal and Newborn Genetic Testing Market Growth
Several types of genetic diseases affect the fetuses in the womb. The way in which these genetic diseases are inherited helps to determine the risk that they pose on pregnancy as well as the risk of its recurrence. The risk of having genetic diseases in babies is high in cases where the parents have another child with a genetic disease, family history of a genetic disorder, or if either of a parent has a chromosomal abnormality. There is a significant prevalence of genetic diseases among infants. Moreover, these diseases are also responsible for infant mortality across the globe. For instance, according to the World Health Organization 2016, an estimated 7.9 million infants across world are born with genetic defects. Moreover, according to the Centers for Disease Control and Prevention (CDC), birth defects affects every 1 in 33 babies born in the US. On the other hand, chromosomal abnormalities such as Down syndrome affects 1 in 691 babies born in the US, as per the CDC’s data in 2017.
On the other hand, a survey conducted by John Hopkins University in 2015 states that approximately 20-30% of infant deaths are a result of genetic disorders. Some of the major genetically determined metabolic diseases include sickle cell anemia, phenylketonuria, thalassemia, and others. Down syndrome is the most common chromosomal disorder that affects around 6000 babies in the US, according to the CDC’s statistics. Moreover, according to a report published by Stanford’s Children Health in 2018, sickle cell anemia occurs in almost 1 out 365 black African-American births. Thus, the high prevalence of genetic diseases among infants account for the increasing demands for prenatal and newborn genetic tests, thereby contributing to the growth of the market.
Product -Based Insights
In terms of product, the global prenatal and newborn genetic testing market is segmented into screening and diagnostics. In 2018, the screening segment held largest share of the market. Also, the same segment is estimated to register the highest CAGR during the forecast period.
Global Prenatal and Newborn Genetic Testing Market, by Product– 2018 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Disease Indication-Based Insights
In terms of disease indication, the global prenatal and newborn genetic testing market is segmented into cystic fibrosis, sickle cell anemia, downs syndrome, phenylketonuria and other diseases. In 2018, the down syndrome segment held largest share of the market. However, the cystic fibrosis segment is expected to register the highest CAGR during the forecast period.
End User-Based Insights
In terms of end user, the global prenatal and newborn genetic testing market is segmented into hospitals & clinics, diagnostic centers and other end user. The hospitals and clinics segment held the largest share of the market in 2018. However, the diagnostics segment is estimated to grow at the fastest rate during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Prenatal and Newborn Genetic Testing Market: Strategic Insights
Market Size Value in US$ 4,034.4 Million in 2018 Market Size Value by US$ 11,204.7 Million by 2027 Growth rate CAGR of 12.2% from 2019-2027 Forecast Period 2019-2027 Base Year 2019
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Prenatal and Newborn Genetic Testing Market: Strategic Insights
| Market Size Value in | US$ 4,034.4 Million in 2018 |
| Market Size Value by | US$ 11,204.7 Million by 2027 |
| Growth rate | CAGR of 12.2% from 2019-2027 |
| Forecast Period | 2019-2027 |
| Base Year | 2019 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The global prenatal and newborn genetic testing market players are adopting the product launches, partnerships, and acquisitions to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
Global Prenatal and Newborn Genetic Testing Market – by Product
- Diagnostic
- Spectrophotometer
- Polymerase Chain Reaction
- Fluorescence in-situ Hybridization
- Array-Comparative Genomic Hybridization
- Screening
- Maternal Serum Screening
- Chronic Villus Sampling
- Amniocentesis
- Non-invasive Prenatal Testing
Global Prenatal and Newborn Genetic Testing Market – by Disease Indication
- Cystic Fibrosis
- Sickle Cell Anemia
- Down Syndrome
- Phenylketonuria
- Other Diseases
Global Prenatal and Newborn Genetic Testing Market – by End- User
- Hospitals & Clinics
- Diagnostic Centres
- Other End Users
Global Prenatal and Newborn Genetic Testing Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South America and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Abbott
- Quest Diagnostics Incorporated
- Ravgen
- Bio-Rad Laboratories, Inc.,
- Illumina, Inc.
- F. Hoffmann La-Roche Ltd.
- Qiagen
- Berry Gene
- PerkinElmer, Inc.
- Natera, Inc.
- Laboratory Corporation of America Holdings (Sequenom)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product , Disease , End User and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Prenatal and Newborn Genetic Testing Market – By Product
1.3.2 Global Prenatal and Newborn Genetic Testing Market – By Disease Indication
1.3.3 Global Prenatal and Newborn Genetic Testing Market – By End User
1.3.4 Global Prenatal and Newborn Genetic Testing Market – By Geography
2. Global Prenatal And Newborn Genetic Testing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Prenatal And Newborn Genetic Testing– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East & Africa– PEST Analysis
4.2.5 South & Central America – PEST Analysis
5. Global Prenatal And Newborn Genetic Testing Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 High Prevalence of Genetic Diseases in Infants
5.1.2 Government Support to Promote Prenatal and Newborn Testing
5.1.3 Increasing Birth Rate
5.2 Key Market Restraints
5.2.1 Risks Associated with Prenatal Testing
5.3 Key Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Digital Microfluidics Poses a New Opportunity Area for the Newborn Screening Market
5.5 Impact Analysis
6. Prenatal And Newborn Genetic Testing Market – Global Analysis
6.1 Global Prenatal And Newborn Genetic Testing Market Revenue Forecasts And Analysis
6.2 Global Prenatal And Newborn Genetic Testing Market, By Geography - Forecasts And Analysis
6.3 Performance of Key Players
6.3.1 F. Hoffmann La-Roche Ltd.
6.3.2 Laboratory Corporation of America Holdings (Sequenom)
6.3.3 PerkinElmer, Inc.
7. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 – Product
7.1 Overview
7.2 Global Prenatal and Newborn Genetic Testing Market Share By Product 2018 & 2027 (%)
7.3 Diagnostic Market
7.3.1 Overview
7.3.2 Diagnostic Market Revenue and Forecast to 2027 (US$ Mn)
7.3.3 Spectrophotometer Market
7.3.3.1 Overview
7.3.3.2 Spectrophotometer Market Revenue and Forecast to 2027 (US$ Mn)
7.3.4 Polymerase Chain Reaction Market
7.3.4.1 Overview
7.3.4.2 Polymerase Chain Reaction Market Revenue and Forecast to 2027 (US$ Mn)
7.3.5 Fluorescence in-situ Hybridization Market
7.3.5.1 Overview
7.3.5.2 Fluorescence in-situ Hybridization Market Revenue and Forecast to 2027 (US$ Mn)
7.3.6 Array Comparative Genomic Hybridization Market
7.3.6.1 Overview
7.3.6.2 Array Comparative Genomic Hybridization Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Screening Market
7.4.1 Overview
7.4.2 Screening Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3 Maternal Serum Screening Market
7.4.3.1 Overview
7.4.3.2 Maternal Serum Screening Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4 Chorionic Villus Sampling Market
7.4.4.1 Overview
7.4.4.2 Chorionic Villus Sampling Market Revenue and Forecast to 2027 (US$ Mn)
7.4.5 Amniocentesis Market
7.4.5.1 Overview
7.4.5.2 Amniocentesis Market Revenue and Forecast to 2027 (US$ Mn)
7.4.6 Non-Invasive Prenatal Testing Market
7.4.6.1 Overview
7.4.6.2 Non-Invasive Prenatal Testing Market Revenue and Forecast to 2027 (US$ Mn)
8. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 – Disease Indication
8.1 Overview
8.2 Global Prenatal and Newborn Genetic Testing Market Share By Disease Indication 2018 & 2027 (%)
8.3 Cystic Fibrosis
8.3.1 Overview
8.3.2 Cystic Fibrosis Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Sickle Cell Anemia
8.4.1 Overview
8.4.2 Sickle Cell Anemia Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Down Syndrome
8.5.1 Overview
8.5.2 Downs Syndrome Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Phenylketonuria
8.6.1 Overview
8.6.2 Phenylketonuria Market Revenue and Forecast to 2027 (US$ Mn)
8.7 Other Diseases
8.7.1 Overview
8.7.2 Other Diseases Market Revenue and Forecast to 2027 (US$ Mn)
9. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 – End User
9.1 Overview
9.2 Global Prenatal And Newborn Genetic Testing Market Share By End User 2018 & 2027 (%)
9.3 Hospitals & Clinics
9.3.1 Overview
9.3.2 Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Diagnostics Centers
9.4.1 Overview
9.4.2 Diagnostics Centers Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Other End Users
9.5.1 Overview
9.5.2 Global Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)
10. Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 – Geographical Analysis
10.1 North America Prenatal And Newborn Genetic Testing Market
10.1.1 Overview
10.1.2 North America Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.3 North America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.3.1 North America Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.2 North America Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.4 North America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.5 North America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2 North America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Country (%)
10.3 US Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
10.3.1 US Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.1.1 US Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.1.1.1 US Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.1.1.2 US Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.1.2 US Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.3.1.3 US Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.4 Canada Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
10.4.1 Canada Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.1.1 Canada Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.4.1.1.1 Canada Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.4.1.1.2 Canada Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.4.1.2 Canada Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.4.1.3 Canada Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.5 Mexico Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
10.5.1 Mexico Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.1.1 Mexico Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.5.1.1.1 Mexico Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.5.1.1.2 Mexico Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.5.1.2 Mexico Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.5.1.3 Mexico Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.6 Europe Prenatal And Newborn Genetic Testing Market
10.6.1 Overview
10.6.2 Europe Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027 (US$ Mn)
10.6.3 Europe Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.6.3.1 Europe Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.3.2 Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.4 Europe Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.6.5 Europe Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.6.6 Europe Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)
10.6.7 Germany Prenatal and Newborn Genetic Testing Market
10.6.7.1 Germany Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.6.7.2 Germany Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.6.7.2.1 Germany Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.7.2.2 Germany Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.7.3 Germany Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.6.7.4 Germany Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.6.8 UK Prenatal and Newborn Genetic Testing Market
10.6.8.1 UK Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.6.8.2 UK Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.6.8.2.1 UK Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.8.2.2 UK Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.8.3 UK Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.6.8.4 UK Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.6.9 France Prenatal and Newborn Genetic Testing Market
10.6.9.1 France Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.6.9.2 France Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.6.9.2.1 France Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.9.2.2 France Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.9.3 France Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.6.9.4 France Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.6.10 Spain Prenatal and Newborn Genetic Testing Market
10.6.10.1 Spain Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.6.10.2 Spain Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.6.10.2.1 Spain Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.10.2.2 Spain Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.10.3 Spain Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.6.10.4 Spain Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.6.11 Italy Prenatal and Newborn Genetic Testing Market
10.6.11.1 Italy Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.6.11.2 Italy Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.6.11.2.1 Italy Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.11.2.2 Italy Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.6.11.3 Italy Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.6.11.4 Italy Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.7 Asia Pacific Prenatal And Newborn Genetic Testing Market
10.7.1 Overview
10.7.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.3 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.7.3.1 Asia Pacific Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.7.3.2 Asia Pacific Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.7.4 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.7.5 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.8 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)
10.8.1 China Prenatal And Newborn Genetic Testing Market
10.8.1.1 China Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.1.2 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.8.1.2.1 China Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.1.2.2 China Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.1.3 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.8.1.4 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.8.2 Japan Prenatal And New born Genetic Testing Market
10.8.2.1 Japan Prenatal And New Born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.2.2 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.8.2.2.1 Japan Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.2.2.2 Japan Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.2.3 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.8.2.4 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.8.3 India Prenatal And New born Genetic Testing Market
10.8.3.1 India Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.3.2 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.8.3.2.1 India Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.3.2.2 India Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.3.3 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.8.3.4 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.8.4 Australia Prenatal And New Born Genetic Testing Market
10.8.4.1 Australia Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.4.2 Australia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.8.4.2.1 Australia Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.4.2.2 Australia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.4.3 Australia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.8.4.4 Australia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.8.5 South Korea Prenatal And Newborn Genetic Testing Market
10.8.5.1 South Korea Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.5.2 South Korea Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.8.5.2.1 South Korea Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.5.2.2 South Korea Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.8.5.3 South Korea Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.8.5.4 South Korea Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.9 Middle East And Africa Prenatal And Newborn Genetic Testing Market
10.9.1 Overview
10.9.2 Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.9.2.1 Middle East & Africa Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.9.2.2 Middle East & Africa Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.9.3 Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.9.4 Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.10 Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)
10.10.1 UAE Prenatal And New born Genetic Testing Market
10.10.1.1 UAE Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.10.1.2 UAE Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.10.1.2.1 UAE Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.10.1.2.2 UAE Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.10.1.3 UAE Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.10.1.4 UAE Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.10.2 Saudi Arabia Prenatal And Newborn Genetic Testing Market
10.10.2.1 Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.10.2.2 Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.10.2.2.1 Saudi Arabia Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.10.2.2.2 Saudi Arabia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.10.2.3 Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.10.2.4 Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.10.3 South Africa Prenatal And Newborn Genetic Testing Market
10.10.3.1 South Africa Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.10.3.2 South Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.10.3.2.1 South Africa Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.10.3.2.2 South Africa Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.10.3.3 South Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.10.3.4 South Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.11 South And Central America Prenatal And Newborn Genetic Testing Market
10.11.1 Overview
10.11.2 South and Central America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027 (US$ Mn)
10.11.3 South and Central America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.11.3.1 South and Central America Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.11.3.2 South and Central America Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.11.4 South and Central America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.11.5 South and Central America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.11.6 South and Central America Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)
10.11.7 Brazil Prenatal and Newborn Genetic Testing Market
10.11.7.1 Brazil Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.11.7.2 Brazil Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.11.7.2.1 Brazil Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.11.7.2.2 Brazil Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.11.7.3 Brazil Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.11.7.4 Brazil Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.11.8 Argentina Prenatal and Newborn Genetic Testing Market
10.11.8.1 Argentina Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.11.8.2 Argentina Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.11.8.2.1 Argentina Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.11.8.2.2 Argentina Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.11.8.3 Argentina Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.11.8.4 Argentina Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11. Prenatal And Newborn Genetic Testing Market – Industry Landscape
11.1 Overview
11.2 Comparative Company Analysis
11.3 Growth Strategies Done by the Companies in the Market, (%)
11.4 Organic Developments
11.4.1 Overview
11.5 Inorganic Developments
11.5.1 Overview
12. Prenatal And Newborn Genetic Testing Market–Key Company Profiles
12.1 Abbott
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Quest Diagnostics Incorporated
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Ravgen
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 F. Hoffmann-La Roche Ltd.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Qiagen N.V.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bio-Rad Laboratories, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Information
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Berry Gene
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 PerkinElmer, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Natera, Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Laboratory Corporation Of America Holdings (Sequenom)
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Illumina, Inc.
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Financial Overview
12.11.4 Product Portfolio
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary Of Terms
LIST OF TABLES
Table 1. North America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 2. North America Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 3. North America Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 4. North America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 5. North America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 6. US Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 7. US Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 8. US Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 9. US Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 10. US Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 11. Canada Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 12. Canada Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 13. Canada Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 14. Canada Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 15. Canada Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 16. Mexico Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 17. Mexico Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 18. Mexico Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 19. Mexico Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 20. Mexico Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 21. Europe Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 22. Europe Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 23. Europe Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 24. Europe Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 25. Europe Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 26. Germany Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 27. Germany Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 28. Germany Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 29. Germany Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 30. Germany Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 31. UK Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 32. UK Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 33. UK Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 34. UK Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 35. UK Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 36. France Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 37. France Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 38. France Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 39. France Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 40. France Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 41. Spain Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 42. Spain Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 43. Spain Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 44. Spain Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 45. Spain Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 46. Italy Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 47. Italy Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 48. Italy Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 49. Italy Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 50. Italy Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 51. Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 52. Asia Pacific Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 53. Asia Pacific Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 54. Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 55. Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 56. China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 57. China Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 58. China Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 59. China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 60. China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 61. Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 62. Japan Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 63. Japan Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 64. Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 65. Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 66. India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 67. India Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 68. India Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 69. India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 70. India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 71. Australia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 72. Australia Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 73. Australia Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 74. Australia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 75. Australia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 76. South Korea Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 77. South Korea Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 78. South Korea Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 79. South Korea Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 80. South Korea Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 81. Middle East & Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 82. Middle East & Africa Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 83. Middle East & Africa Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 84. Middle East & Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 85. Middle East & Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 86. UAE Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 87. UAE Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 88. UAE Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 89. UAE Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 90. UAE Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 91. Saudi Arabia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 92. Saudi Arabia Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 93. Saudi Arabia Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 94. Saudi Arabia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 95. Saudi Arabia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 96. South Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 97. South Africa Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 98. South Africa Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 99. South Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 100. South Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 101. South And Central America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 102. South And Central America Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 103. South And Central America Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 104. South And Central America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 105. South And Central America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 106. Brazil Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 107. Brazil Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 108. Brazil Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 109. Brazil Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 110. Brazil Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 111. Argentina Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 112. Argentina Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 113. Argentina Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 114. Argentina Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 115. Argentina Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 116. Organic Developments Done By Companies
Table 117. Inorganic Developments Done By Companies
Table 118. Glossary Of Terms, Prenatal And Newborn Genetic Testing Market
LIST OF FIGURES
Figure 1. Prenatal And Newborn Genetic Testing Market Segmentation
Figure 2. Prenatal And Newborn Genetic Testing Segmentation, By Region
Figure 3. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue (US$ Mn), 2018 & 2027
Figure 4. Global Prenatal And Newborn Genetic Testing Market By Product, Market Share (%), 2018
Figure 5. Global Prenatal And Newborn Genetic Testing Market By Disease Indication, Market Share (%), 2018
Figure 6. Global Prenatal And Newborn Genetic Testing Market By End User, Market Share (%), 2018
Figure 7. North America PEST Analysis
Figure 8. Europe PEST Analysis
Figure 9. Asia Pacific PEST Analysis
Figure 10. Middle East & Africa PEST Analysis
Figure 11. South & Central America PEST Analysis
Figure 12. Prenatal And Newborn Genetic Testing Market Impact Analysis of Driver And Restraints
Figure 13. Global Prenatal And Newborn Genetic Testing Market – Revenue Forecasts And Analysis – 2018- 2027
Figure 14. Global Prenatal And Newborn Genetic Testing Market – By Geography Forecasts And Analysis – 2018- 2027
Figure 15. Global Prenatal and Newborn Genetic Testing Market Share By Product 2018 & 2027 (%)
Figure 16. Diagnostic Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 17. Spectrophotometer Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 18. Polymerase Chain Reaction Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 19. Fluorescence In-Situ Hybridization Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 20. Array Comparative Genomic Hybridization Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 21. Screening Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 22. Maternal Serum Screening Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 23. Chorionic Villus Sampling Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 24. Amniocentesis Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 25. Non-Invasive Prenatal Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 26. Global Prenatal and Newborn Genetic Testing Market Share By Disease Indication 2018 & 2027 (%)
Figure 27. Cystic Fibrosis Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 28. Sickle Cell Anemia Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 29. Downs Syndrome Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 30. Phenylketonuria Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 31. Other Diseases Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 32. Global Prenatal and Newborn Genetic Testing Market Share By End User 2018 & 2027 (%)
Figure 33. Global Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 34. Diagnostics Centers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 35. Global Other End User Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 36. North America Prenatal And Newborn Genetic Testing Market REVENUE Overview, By Country, 2018 (US$ MN)
Figure 37. North America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 38. North America Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)
Figure 39. US Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 40. Canada Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 41. Mexico Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 42. Europe Prenatal And Newborn Genetic Testing Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 43. Europe Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 44. Europe Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)
Figure 45. Germany Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 46. UK Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 47. France Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 48. Spain Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 49. Italy Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 50. Asia Pacific Prenatal And Newborn Genetic Testing Market REVENUE Overview, By Country, 2018 (US$ MN)
Figure 51. Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 52. Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)
Figure 53. China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 54. Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 55. India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 56. Australia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 57. South Korea Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 58. Middle East And Africa Prenatal And Newborn Genetic Testing Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 59. Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)
Figure 60. UAE Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 61. Saudi Arabia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 62. South Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 63. South And Central America Prenatal And Newborn Genetic Testing Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 64. South And Central America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 65. South and Central America Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)
Figure 66. Brazil Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 67. Argentina Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 68. Comparative Company Analysis
Figure 69. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies
- Abbott
- Quest Diagnostics Incorporated
- Ravgen
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- F. Hoffmann La-Roche Ltd.
- Qiagen
- Berry Gene
- PerkinElmer, Inc.
- Natera, Inc.
- Laboratory Corporation of America Holdings (Sequenom)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Prenatal and Newborn Genetic Testing Market
Jul 2019
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jul 2019
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2019
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jul 2019
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jul 2019
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jul 2019
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jul 2019
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Jul 2019